MET and neoplasm: In conclusion, this viable strategy reported here not only exhibits remarkable selectivity in suppressing the Wnt/β‐catenin signaling pathway in response to both the acidic microenvironment and MET amplification of the tumor, but also serves as an exemplary demonstration of precision‐medicine‐guided target discovery and drug development.